Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
AskBio Announces IND for LION-101 Cleared to Proceed by U.S. FDA
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that […]
Pink Luminous Breast (PLB) Takes Steps Toward FDA Class III Approval
Pink Luminous Breast (PLB) is continuing to make strides in breast cancer awareness with a new […]
Amgen Tezepelumab BLA Submitted to U.S. FDA
Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to […]
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food […]
Pfizer and BioNTech Initiate BLA for FDA Approval of Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application […]
Viome Receives FDA Approval for its Unique mRNA Technology and AI Platform to Detect Cancers
Viome, a mission-driven bioscience company focused on helping individuals improve their health, today announced its […]
FDA Accepts Amgen's sNDA For Otezla ®
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for […]
ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]
RETINA-AI Health Awarded U.S. Patent for AI Eye Disease Detection
RETINA-AI Health Inc. has been awarded a U.S. patent on its Artificial Intelligence (AI) systems […]
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer
Today, the U.S. Food and Drug Administration (FDA) authorized marketing of the GI Genius, the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more